【摘要】 目的探讨经尿道柱状水囊前列腺扩开术(TUCBDP)治疗良性前列腺增生(BPH)的临床疗效。方法回顾性分析42例BPH患者的临床资料,患者均行TUCBDP治疗,观察手术效果。结果 42例患者手术均顺利完成, 37例一次扩开, 5例经二次扩开;12点扩开36例, 12点、6点同时扩开6例。手术时间21～46 min,平均手术时间(32.0±16.0)min。术后留置导尿管时间4～6 d,平均留置导尿管时间(4.1±1.8)d。术后住院时间为6～8 d,平均住院时间(5.6±1.6)d。未发生明显出血,无输血病例。术后尿失禁4例(9.52%), 2个月内尿失禁症状消失,排尿通畅。手术前血红蛋白浓度为(122.0±2.8)g/L,手术后血红蛋白浓度为(120.7±3.6)g/L,比较差异无统计学意义(P>0.05)。术后3个月,国际前列腺症状评分量表(IPSS)评分由术前(16.5±7.8)分降至术后(6.2±2.3)分,最大尿流率(Qmax)由术前(7.2±1.8)ml/s增至(33.4±11.7)ml/s,生活质量指数评分量表(QOL)评分由术前(5.2±0.8)分降至术后(1.5±0.7)分,剩余尿量(RUV)由术前(80.2±37.9)ml减少至术后(13.2±2.3)ml;手术前后IPSS评分、Qmax、QOL评分、RUV比较差异均有统计学意义(P<0.05)。术后6个月,勃起功能障碍15例,逆行射精3例,与术前比较差异无统计学意义(P>0.05)。结论 TUCBDP治疗BPH具有创伤小、手术简单易掌握、术后并发症少、安全性高等优点,临床疗效满意。更多还原

【Abstract】 Objective To discuss the clinical efficacy of benign prostatic hyperplasia(BPH) treated by transurethral columnar balloon dilation of the prostate(TUCBDP). Methods The clinical data of 42 BPH patients were retrospectively analyzed. All patients were treated with TUCBDP, and the effect of surgery was observed. Results All the operations were successfully completed in 42 patients, 37 cases were dilated once, 5 cases were dilated twice, 36 cases were dilated at 12 o’clock, 6 cases were dilated at 12 o’clock and 6 o’clock at the same time. The operation time was 21-46 min, and the average operation time was(32.0± 16.0) min; the postoperative catheterization time was 4-6 d, and the average catheterization time was(4.1±1.8) d; the postoperative hospitalization time was 6-8 d, and the average hospitalization time was(5.6±1.6) d. No significant bleeding occurred, and there was no case of blood transfusion. 4 cases(9.52%) had urinary incontinence after operation. The symptoms of urinary incontinence disappeared within 2 months and the urination was unobstructed. The hemoglobin concentration was(122.0±2.8) g/L before the operation, and the hemoglobin concentration was(120.7±3.6) g/L after the operation, and the difference was not statistically significant(P>0.05). After 3 months of follow-up, the international prostate symptom scale(IPSS) score decreased from preoperative(16.5±7.8) points to postoperative(6.2±2.3) points; the maximum urine flow rate(Qmax) increased from preoperative(7.2±1.8) ml/s to postoperative(33.4±11.7)ml/s; quality of life(QOL) score decreased from preoperative(5.2±0.8) points to postoperative(1.5±0.7) points; residual urine volume(RUV) decreased from preoperative(80.2±37.9) ml to postoperative(13.2±2.3) ml; the differences in IPSS score, Qmax, QOL score, RUV before and after operation were statistically significant(P<0.05). At 6 months after operation, there were 15 cases of erectile dysfunction and 3 cases of retrograde ejaculation. There was no statistically significant difference compared with preoperation(P>0.05). Conclusion TUCBDP has the advantages of less trauma, simple and easy operation, less postoperative complications, high safety in the treatment of BPH, and the clinical efficacy is satisfactory.更多还原